On 17 October 2001, Health Canada approved the sale of Trizivir tablets in Canada. Trizivir contains the following three drugs:
Trizivir was approved for the treatment of adults with HIV/AIDS, at a dose of one tablet twice daily, with or without food. Side effects that may occur from Trizivir include the following:
Abacavir can cause a hypersensitivity reaction. People with HIV/AIDS who experience this reaction should never use abacavir or Trizivir again.
The cost of a month's supply of Trizivir is about $945 CND, which is the cost of buying all three drugs separately. A CATIE Fact Sheet on Trizivir is under development and will be available shortly.
20011210
CATE12312
Copyright © 2001 - TreatmentUpdate. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Editor, The Canadian AIDS Treatment Information Exchange, 555 Richmond St. West, Suite 505, Box 1104, Toronto, ON, M5V 3B1 • Phone: 416-203-7122 • Toll Free: 1-800-263-1638 • Fax: 416-203-8284 http://www.catie.ca.
AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, iMetrikus, Inc., the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
